Inventor · disambiguated record
David Helton
Also filed as: HELTON DAVID · HELTON DAVID R · HELTON DAVID REED
25 granted patents·11 pending applications·338 citations·filing 1993–2019
96Inventor score
Files withLILLY CO ELI10HELTON DAVID7HELTON DAVID REED6SPECTRUM PHARMACEUTICALS INC4REPURPOSED THERAPEUTICS INC3
Top patents by PatentIndex Score
36 records- 0195US6444665B1Method for treating painLILLY CO ELI·Filed 2000·Granted Sep 3, 2002·79 cites·42 claims
- 0289US6770638B2Tetrahydroindolone and purine derivatives linked to arylpiperazinesSPECTRUM PHARMACEUTICALS INC·Filed 2002·Granted Aug 3, 2004·22 cites·12 claims
- 0389US5916920A3-substituted Bicyclo 3.1.0!hexane-6-carboxylic acidsLILLY CO ELI·Filed 1996·Granted Jun 29, 1999·58 cites·13 claims
- 0485US6982269B2Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivativesSPECTRUM PHARMACEUTICALS INC·Filed 2002·Granted Jan 3, 2006·16 cites·17 claims
- 0584US8063233B2Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivativesGLASKY ALVIN J·Filed 2009·Granted Nov 22, 2011·5 cites·9 claims
- 0682US6936601B2Compositions for treating painLILLY CO ELI·Filed 2002·Granted Aug 30, 2005·11 cites·10 claims
- 0781US8377456B2Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivativesSPECTRUM PHARMACEUTICALS INC·Filed 2011·Granted Feb 19, 2013·3 cites·26 claims
- 0880US8637263B1Assay for determination of compounds having anti-emetic activityHELTON DAVID REED·Filed 2011·Granted Jan 28, 2014·4 cites·15 claims
- 0979US5925680ASynthetic excitatory amino acidsLILLY CO ELI·Filed 1997·Granted Jul 20, 1999·17 cites·15 claims
- 1078US7531670B2Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivativesSPRECTRUM PHARMACEUTICALS INC·Filed 2004·Granted May 12, 2009·9 cites·2 claims
- 1175US5661184APsychiatric agentsLILLY CO ELI·Filed 1995·Granted Aug 26, 1997·37 cites·26 claims
- 1275US5399565APyrazolidinone CCK and gastrin antagonists and pharmaceutical formulations therofLILLY CO ELI·Filed 1993·Granted Mar 21, 1995·19 cites·19 claims
- 1374US5717109AExcitatory amino acid receptor antagonistsLILLY CO ELI·Filed 1995·Granted Feb 10, 1998·16 cites·14 claims
- 1473US8734818B2Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivativesSPECTRUM PHARMACEUTICALS INC·Filed 2013·Granted May 27, 2014·1 cites·26 claims
- 1569US10646457B2Emesis treatmentREPURPOSED THERAPEUTICS INC·Filed 2019·Granted May 12, 2020·0 cites·17 claims
- 1669US2009156609A1Treatment of post-traumatic stress disorder with tetrahydroindolone arylpiperzaine compoundsHELTON DAVID·Filed 2008·Application pending·0 cites
- 1764US10478438B2Treatment of organophosphate exposure with ocinaplonHELTON DAVID REED·Filed 2009·Granted Nov 19, 2019·0 cites·8 claims
- 1864US7795266B2Tetrahydroindolone derivatives for treament of neurological conditionsHELTON DAVID R·Filed 2004·Granted Sep 14, 2010·5 cites·6 claims
- 1961US2009264443A1Treatment of organophosphate exposure with tetrahydroindolone arylpiperazine compoundsHELTON DAVID·Filed 2008·Application pending·0 cites
- 2060US10206889B2Emesis treatmentREPURPOSED THERAPEUTICS INC·Filed 2018·Granted Feb 19, 2019·0 cites·5 claims
- 2160US9918949B2Emesis treatmentREPURPOSED THERAPEUTICS INC·Filed 2014·Granted Mar 20, 2018·0 cites·18 claims
- 2256US6258807B1Method for treating painLILLY CO ELI·Filed 1997·Granted Jul 10, 2001·12 cites·17 claims
- 2356US2015051219A1Treatment of organophosphate exposure with tetrahydroindolone arylpiperazine compoundsHELTON DAVID REED·Filed 2014·Application pending·0 cites
- 2455US5882671AAnxiolytic agentsLILLY CO ELI·Filed 1997·Granted Mar 16, 1999·12 cites·6 claims
- 2555US2022000881A1Treatment of exposure to chlorine gas with scopolamineREPURPOSED THERAPEUTICS INC DBA DEFENDER·Filed 2019·Application pending·0 cites
- 2653US2020188403A1Treatment of organophosphate exposure with ocinaplonHELTON DAVID·Filed 2019·Application pending·0 cites
- 2753US2005107439A1Composition and method for treating emesisFiled 2004·Application pending·0 cites
- 2852US10736878B2Treatment of organophosphate exposure with triptansPFADENHAUER TINA·Filed 2013·Granted Aug 11, 2020·0 cites·9 claims
- 2952US10398687B2Use of cyproheptadine to treat organophosphate exposureHELTON DAVID REED·Filed 2011·Granted Sep 3, 2019·0 cites·11 claims
- 3052US6242462B1Pharmacological agentsLILLY CO ELI·Filed 1998·Granted Jun 5, 2001·12 cites·4 claims
- 3152US2020085808A1Use of cyproheptadine to treat organophosphate exposureHELTON DAVID REED·Filed 2019·Application pending·0 cites
- 3250US2011172242A1Treatment of organophosphate exposure with tetrahydroindolone arylpiperazine compoundsHELTON DAVID·Filed 2010·Application pending·0 cites
- 3350US2012208892A1Emesis treatmentHELTON DAVID·Filed 2010·Application pending·0 cites
- 3446US2011294823A1Treatment of post-traumatic stress disorder with tetrahydroindolone arylpiperzaine compoundsHELTON DAVID·Filed 2011·Application pending·0 cites
- 3541US8598180B2Tetrahydroindolone derivatives for treatment of neurological conditionsHELTON DAVID REED·Filed 2010·Granted Dec 3, 2013·0 cites·7 claims
- 3641US2013289047A1Heteroarylthio derivatives and analoguesHELTON DAVID·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Helton files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →